MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Fate Therapeutics, Inc.

FATE

#3409
Fate Therapeutics, Inc. - Common Stock
2.0 0 USD
-0.06%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.98
2.13
Year Range
0.95
3.23
Daily Change
-6.10%
Monthly Change
-13.04%
6 month change
+49.25%
Year Change
+44.93%
Previous Close
2.1 3
Open
2.1 3
Low
1.9 8
High
2.1 3
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. Biotechnology
  5. FATE
Open full chart

Financials

Overview Statement Statistics Documents

2013

Quarterly report, Q3 FY2013

2013.11.13
FATE THERAPEUTICS INC quarterly report, Q3 FY2013
10-Q
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8

News

Benzinga
FATE
2026.09.25

Fate Therapeutics Receives $15M CIRM Grant To Advance Phase 2 FT819 Trial In Lupus Nephritis

Seeking Alpha
FATE
2026.09.02

Fate Therapeutics: RECLAIM-LN Underway, Additional Clinical Updates Ahead (NASDAQ:FATE)

Zacks
GLUE FATE
2026.08.06

Monte Rosa Therapeutics (GLUE) Reports Q2 Loss, Misses Revenue Estimates

Seeking Alpha
FATE LGND EXEL PTCT XLV
2026.07.11

Macro Note: The Tech Unwind Grew A Second Leg, And It’s Healthcare

Seeking Alpha
FATE
2026.06.24

Fate Therapeutics’s FT819 Progress Keeps My Bull Case Alive (NASDAQ:FATE)

Seeking Alpha
BP AAPL AZO MU AGEN
2026.05.26

Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concern

TipRanks
OCGN SENS NKTR AGEN CTMX
2026.05.26

5 Healthcare Stocks Set to Join the Russell 3000 - TipRanks.com

Zacks
FATE ROIV
2026.05.13

Fate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue Estimates

Zacks
CAMP FATE
2026.05.07

CAMP4 Therapeutics Corporation (CAMP) Reports Q1 Loss, Lags Revenue Estimates

Zacks
FHTX FATE
2026.05.06

Foghorn Therapeutics Inc. (FHTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks
NVAX FATE
2026.05.06

Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates

Investing
FATE
2026.03.09

Fate Therapeutics at Leerink Global Healthcare Conference: Strategic Shift in Focus

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stocks
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Subscribe to algo trading news
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd